Low blood ISG15 mRNA and progesterone levels are predictive of non-pregnant dairy cows
Authors:
- Kathleen J AustinKAKathleen J Austin
- Lea A RempelLRLea A Rempel
- Thomas R HansenTHThomas R Hansen
Open Access
- 1 November 2006
- journal article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 191 (2) , 505-512
Abstract
ISG15 is induced by conceptus-derived interferon-τ in the endometrium on days 15–45 of pregnancy. It was hypothesized that pregnancy induces blood cell ISG15 gene expression and that low blood ISG15 mRNA levels provide an indication of non-pregnant cows on day 18. Blood was collected either on day 18 (n = 78) or on days 15–21, 25, and 32 (n = 21; serial collection) from dairy cows following artificial insemination (AI). Plasma progesterone concentration was determined using RIA. ISG15 mRNA levels were determined using real-time PCR. Pregnancy was diagnosed on day 32 using transrectal ultrasound. ISG15 mRNA levels increased after day 16, peaked at day 20 and then declined to day 16 levels by 32 days following AI. The average pregnancy rate was 43% based on blood cell ISG15 mRNA. The average pregnancy rate was 33% based on the transrectal ultrasound. Lower levels of ISG15 mRNA or progesterone during serial collections were 100% accurate in predicting non-pregnant cows based on day 32 transrectal ultrasound. However, detection of ISG15 mRNA yielded 78% accuracy in predicting pregnant cows, while progesterone yielded 58% accuracy. Average plasma progesterone based on pregnancy status according to ultrasound was consistently higher in pregnant (> 4 ng/ml) when compared with non-pregnant cows from days 15 to 32, except on day 16. It is concluded that detection of low blood ISG15 mRNA levels during serial collection from days 17 to 25 serves as an accurate indicator of cows that are not pregnant, thus allowing re-synchronization and insemination.Keywords
This publication has 23 references indexed in Scilit:
- Acute and persistent iatrogenic Cushing’s syndrome after a single dose of triamcinolone acetonideJournal of Endocrinological Investigation, 2005
- A Randomized Clinical Trial of a Single Dose of Intravitreal Triamcinolone Acetonide for Neovascular Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2003
- Intravitreal Injection of Triamcinolone for Diffuse Diabetic Macular EdemaArchives of Ophthalmology (1950), 2003
- The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2003
- Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathyAmerican Journal of Ophthalmology, 2001
- Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horsesJournal of Veterinary Pharmacology and Therapeutics, 2000
- Pharmacokinetic and Pharmacodynamic Evaluation of Triamcinolone Acetonide After Intravenous, Oral, and Inhaled AdministrationThe Journal of Clinical Pharmacology, 1995
- Pharmacokinetics of Triamcinolone Acetonide After Intravenous, Oral, and Inhaled AdministrationThe Journal of Clinical Pharmacology, 1995
- Intrathecal versus systemic corticosteroids in the treatment of multiple sclerosis: results of a pilot studyJournal of Neurology, 1992
- RECOVERY OF HYPOTHALAMO-PITUITARY-ADRENAL FUNCTION AFTER CORTICOSTEROID THERAPYThe Lancet, 1967